Senior insider sale
Chief Scientific Officer at CYTEIR THERAPEUTICS, INC. — senior position signals high conviction
$71.6K
31.36K shares
What this filing means
SECRIST JOHN PAUL plans to sell 31.36K shares of CYTEIR THERAPEUTICS, INC. valued at approximately $71.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2023ACC: 0001972362-23-000441
Officer· Chief Scientific Officer
Since Jun 2021
31.36K
Shares to sell
$71.6K
Approx. market value
18.18K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
6/30/2023
18.18KTotal acquired18.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2023 | STOCK OPTION EXERCISE COMPENSATION | 18.18K | — |
| Total | 18.18K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
13.18K
Market value
$23.2K
6/28/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.18K
Market value
$48.3K
6/30/2023
Total
Units
31.36K
Value
$71.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/28/2023 | 13.18K | $23.2K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2023 | 18.18K | $48.3K | NASDAQ | Planned |
| Total | 31.36K | $71.6K | ||